Anti-SARS-CoV-2 RBD Potent Neutralizing Antibody, Human IgG1 (AM180), Unconjugated
Biozol Catalog Number:
ABS-SPD-M180-100UG
Supplier Catalog Number:
SPD-M180-100ug
Alternative Catalog Number:
ABS-SPD-M180-100UG
Manufacturer:
AcroBiosystems
Host:
Human
Category:
Antikörper
Species Reactivity:
Human
Conjugation:
Unconjugated
AntiSARSCoV2 RBD Potent Neutralizing Antibody, Human IgG1 (AM180) is isolated from a SARSCoV2 infected patient and is recombinantly produced from human 293 cells (HEK293). This antibody recognizes the SARSCoV2 Spike Protein RBD domain and inhibits the interaction between SARSCoV2 RBD and ACE2 with an IC50 of 0.98 µg/mL using SARSCoV2 Inhibitor Screening Kit.Pseudovirus assay shows that this antibody has potent neutralizing activity against pseudovirus bearing SARSCoV2 Spike protein. - Antikörper
Tag:
Human IgG1 | Human Kappa
Buffer:
PBS, pH7.4
Purity:
0.95
Form:
Powder
Target:
Spike RBD
Immobilized SARS-CoV-2 S protein RBD, His Tag (Cat. No. SPD-C52H3) at 1 µg/mL (100 µL/well) can bind Anti-SARS-CoV-2 RBD Potent Neutralizing Antibody, Human IgG1 (AM180) (Cat. No. SPD-M180) with a linear range of 0.2-2 ng/mL (QC tested).
Serial dilutions of Anti-SARS-CoV-2 RBD Potent Neutralizing Antibody, Human IgG1 (AM180) (Cat. No. SPD-M180) were added into SARS-CoV-2 S protein RBD, His Tag (Cat. No. SPD-C52H3): Biotinylated Human ACE2, His,Avitag (Cat. No. AC2-H82E6) binding reactions. The half maximal inhibitory concentration (IC50) is 0.98269 µg/mL (Routinely tested).
Anti-SARS-CoV-2 RBD Potent Neutralizing Antibody, Human IgG1 (AM180) on SDS-PAGE under reducing (R) condition. The gel was stained overnight with Coomassie Blue. The purity of the protein is greater than 0.95.
* VAT and and shipping costs not included. Errors and price changes excepted
